High Concentration of Soluble Form of Vascular Endo-thelial Cadherin in Sera of Patients with Prostate Cancer


M Habibagahi 1 , * , Z Mostafavipour 2 , M Lotfi 2 , M Dehghani 2 , M Jaberipour 2 , H Dehghan 2

1 Assistant Professor of Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, [email protected], Fars, Iran

2 Urology Research Center, Department of Biochemistry, Shiraz University of Medical Sciences, Fars, Iran

How to Cite: Habibagahi M, Mostafavipour Z, Lotfi M, Dehghani M, Jaberipour M, et al. High Concentration of Soluble Form of Vascular Endo-thelial Cadherin in Sera of Patients with Prostate Cancer, Iran Red Crescent Med J. Online ahead of Print ; 11(4):377-381.


Iranian Red Crescent Medical Journal: 11 (4); 377-381
Article Type: Research Article
Received: February 27, 2009
Accepted: May 17, 2009




Background: For many years, prostate-specific antigen (PSA) was used to screen prostate cancer (PC) patients. However, recent controversial findings have cast doubt on the accuracy of this biomarker for diagnostic and prognostic purposes, and have stimulated the search for new candidates. This study was conducted to determine the capability of a soluble adhesion molecule known as soluble vascular endothelial cadherin (sVE-cadherin) or CD144 to distinguish prostate cancer or benign prostate hyperplasia (BPH) patients from healthy individuals.


Methods: Patients recently diagnosed as having PC (N=35) or BPH (N=35) and age-matched controls (N=30) were study enrolled. The concentration of sVE-cadherin and PSA was measured by ELISA. Gleason score in patients with PC was determined by pathological examination of tumor biopsies.


Results: The concentration of sVE-cadherin in the serum of patients with PC and BPH was significantly higher than that in the healthy men. No association was found between the concentration of this soluble adhesion molecule and PSA values. Moreover, concentrations of sVE-cadherin did not correlate with Gleason scores in patients with PC.


Conclusion: The high concentration of sVE-cadherin in our patients suggests that this bio-marker is a potentially useful tool to identify high-risk patients. However, further research in patients with PC and other pathological conditions is needed to support the efficacy of this molecule in PC screening.


Prostate cancer Soluble vascular endothelial cadherin PSA

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF